Thomas J. Schall Ph.D.
Net Worth

Last updated:

What is Thomas J. Schall Ph.D. net worth?

The estimated net worth of Dr. Thomas J. Schall Ph.D. is at least $183,157,333 as of 4 Aug 2022. He owns shares worth $124,430,370 as insider, has earned $44,036,963 from insider trading and has received compensation worth at least $14,690,000 in ChemoCentryx, Inc..

What is the salary of Thomas J. Schall Ph.D.?

Dr. Thomas J. Schall Ph.D. salary is $1,130,000 per year as Founder, Pres, Chief Executive Officer & Chairman in ChemoCentryx, Inc..

How old is Thomas J. Schall Ph.D.?

Dr. Thomas J. Schall Ph.D. is 66 years old, born in 1959.

What stocks does Thomas J. Schall Ph.D. currently own?

As insider, Dr. Thomas J. Schall Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
ChemoCentryx, Inc. (CCXI) Founder, Pres, Chief Executive Officer & Chairman 2,393,352 $51.99 $124,430,370

What does ChemoCentryx, Inc. do?

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.

CCXI logo
CCXI
ChemoCentryx, Inc.
$51.99

Thomas J. Schall Ph.D. insider trading

ChemoCentryx, Inc.

Dr. Thomas J. Schall Ph.D. has made 77 insider trades between 2012-2022, according to the Form 4 filled with the SEC. Most recently he sold 130,000 units of CCXI stock worth $6,531,720 on 4 Aug 2022.

The largest trade he's ever made was exercising 279,166 units of CCXI stock on 26 Nov 2019. As of 4 Aug 2022 he still owns at least 2,393,352 units of CCXI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 130,000 $50.24 $6,531,720
Option
Common Stock 130,000 $14.28 $1,856,400
Option
Stock Option (right to buy) 130,000 $14.28 $1,856,400
Option
Common Stock 84,234 N/A N/A
Option
Restricted Stock Units 84,234 N/A N/A
Option
Common Stock 45,936 $12.29 $564,553
Option
Stock Option (right to buy) 6,988 $14.31 $99,998
Option
Restricted Stock Units 87,899 N/A N/A
Option
Common Stock 87,899 N/A N/A
Option
Stock Option (right to buy) 17,619 $65.01 $1,145,446
Option
Common Stock 17,619 $65.01 $1,145,446
Sale
Common Stock 17,619 $65.01 $1,145,446
Option
Common Stock 11,153 $14.31 $159,599
Sale
Common Stock 11,153 $14.31 $159,599
Option
Stock Option (right to buy) 11,153 $14.31 $159,599
Option
Common Stock 2,000 $65.05 $130,090
Sale
Common Stock 2,000 $65.05 $130,090
Option
Stock Option (right to buy) 2,000 $65.05 $130,090
Sale
Common Stock 88,753 $14.31 $1,270,055
Option
Stock Option (right to buy) 88,753 $14.31 $1,270,055
Option
Common Stock 88,753 $14.31 $1,270,055
Sale
Common Stock 35,865 $57.75 $2,071,096
Option
Stock Option (right to buy) 35,865 $57.75 $2,071,096
Option
Common Stock 35,865 $57.75 $2,071,096
Sale
Common Stock 70,608 $55.74 $3,935,337
Option
Common Stock 70,608 $14.31 $1,010,400
Option
Stock Option (right to buy) 70,608 $14.31 $1,010,400
Sale
Common Stock 4,201 $14.31 $60,116
Option
Stock Option (right to buy) 4,201 $14.31 $60,116
Option
Common Stock 4,201 $14.31 $60,116
Sale
Common Stock 8,851 $14.31 $126,658
Option
Stock Option (right to buy) 8,851 $14.31 $126,658
Option
Common Stock 8,851 $14.31 $126,658
Option
Stock Option (right to buy) 40,844 $14.31 $584,478
Sale
Common Stock 40,844 $14.31 $584,478
Option
Common Stock 40,844 $14.31 $584,478
Sale
Common Stock 15,341 $50.66 $777,098
Option
Common Stock 15,341 $14.31 $219,530
Option
Stock Option (right to buy) 15,341 $14.31 $219,530
Option
Stock Option (right to buy) 63,340 $14.31 $906,395
Option
Common Stock 63,340 $14.31 $906,395
Sale
Common Stock 63,340 $50.78 $3,216,089
Option
Stock Option (right to buy) 119,525 $14.31 $1,710,403
Sale
Common Stock 119,525 $14.31 $1,710,403
Option
Common Stock 119,525 $14.31 $1,710,403
Option
Common Stock 105,735 $10.27 $1,085,898
Sale
Common Stock 105,735 $41.79 $4,418,983
Option
Stock Option (right to buy) 105,735 $10.27 $1,085,898
Option
Common Stock 30,317 $10.27 $311,356
Option
Stock Option (right to buy) 30,317 $10.27 $311,356
Sale
Common Stock 30,317 $10.27 $311,356
Option
Common Stock 86,667 N/A N/A
Option
Restricted Stock Units 86,667 N/A N/A
Option
Stock Option (right to buy) 279,166 $6.3 $1,758,746
Option
Common Stock 279,166 $6.3 $1,758,746
Sale
Common Stock 279,166 $31.59 $8,818,575
Sale
Common Stock 74,986 $13.86 $1,038,931
Option
Common Stock 74,986 $13.86 $1,038,931
Option
Stock Option (right to buy) 74,986 $13.86 $1,038,931
Sale
Common Stock 79,259 $13.58 $1,076,099
Option
Stock Option (right to buy) 79,259 $13.58 $1,076,099
Option
Common Stock 79,259 $13.58 $1,076,099
Sale
Common Stock 5,755 $6 $34,530
Option
Common Stock 5,755 $6 $34,530
Option
Stock Option (right to buy) 5,755 $6 $34,530
Option
Common Stock 36,762 $6 $220,572
Sale
Common Stock 36,762 $6 $220,572
Option
Stock Option (right to buy) 36,762 $6 $220,572
Sale
Common Stock 12,895 $12 $154,766
Option
Stock Option (right to buy) 12,895 $12 $154,766
Option
Common Stock 12,895 $12 $154,766
Sale
Common Stock 7,275 $6 $43,650
Option
Stock Option (right to buy) 7,275 $6 $43,650
Option
Common Stock 7,275 $6 $43,650
Option
Restricted Stock Units 96,667 N/A N/A
Option
Common Stock 96,667 N/A N/A
Sale
Common Stock 7,211 $6 $43,266
Option
Stock Option (right to buy) 7,211 $6 $43,266
Option
Common Stock 7,211 $6 $43,266
Option
Common Stock 100 $14.1 $1,410
Option
Stock Option (right to buy) 100 $14.1 $1,410
Sale
Common Stock 100 $14.1 $1,410
Option
Stock Option (right to buy) 10,757 $6 $64,542
Option
Common Stock 10,757 $6 $64,542
Sale
Common Stock 10,757 $6 $64,542
Option
Stock Option (Right to Buy) 27,928 $13.01 $363,287
Sale
Common Stock 27,928 $13.01 $363,287
Option
Common Stock 27,928 $13.01 $363,287
Option
Stock Option (Right to buy) 30,932 $13 $402,147
Sale
Common Stock 30,932 $13 $402,147
Option
Common Stock 30,932 $13 $402,147
Option
Stock Option (Right to buy) 33,938 $9.07 $307,886
Sale
Common Stock 33,938 $9.07 $307,886
Option
Common Stock 33,938 $6 $203,628
Sale
Common Stock 17,798 $12.14 $216,139
Option
Stock Option (right to buy) 17,798 $12.14 $216,139
Option
Common Stock 17,798 $12.14 $216,139
Option
Common Stock 82,202 $12.26 $1,007,632
Option
Stock Option (right to buy) 82,202 $12.26 $1,007,632
Sale
Common Stock 82,202 $12.26 $1,007,632
Option
Stock Option (right to buy) 100,000 $6 $600,000
Option
Common Stock 100,000 $6 $600,000
Sale
Common Stock 100,000 $6 $600,000
Option
Common Stock 32,873 $11.03 $362,458
Sale
Common Stock 32,873 $11.03 $362,458
Option
Stock Option (right to buy) 32,873 $11.03 $362,458
Option
Stock Option (right to buy) 17,127 $6 $102,762
Option
Common Stock 17,127 $6 $102,762
Sale
Common Stock 17,127 $6 $102,762
Option
Common Stock 66,666 N/A N/A
Option
Restricted Stock Units 66,666 N/A N/A
Option
Restricted Stock Units 33,333 N/A N/A
Option
Common Stock 33,333 N/A N/A
Sale
Common Stock 6,527 $7.36 $48,045
Option
Common Stock 6,527 $7.36 $48,045
Option
Stock Option (right to buy) 6,527 $7.36 $48,045
Option
Common Stock 16,540 $7.55 $124,927
Option
Stock Option (right to buy) 16,540 $7.55 $124,927
Sale
Common Stock 16,540 $7.55 $124,927
Option
Common Stock 1,200 $0.6 $720
Sale
Common Stock 1,200 $0.6 $720
Option
Stock Option (right to buy) 1,200 $0.6 $720
Option
Stock Option (right to buy) 900 $0.6 $540
Sale
Common Stock 900 $0.6 $540
Option
Common Stock 900 $0.6 $540
Sale
Common Stock 16,765 $7.8 $130,834
Option
Stock Option (right to buy) 16,765 $7.8 $130,834
Option
Common Stock 16,765 $7.8 $130,834
Option
Common Stock 19,291 $7.77 $149,852
Option
Stock Option (right to buy) 19,291 $7.77 $149,852
Sale
Common Stock 19,291 $7.77 $149,852
Option
Stock Option (right to buy) 14,315 $0.6 $8,589
Option
Common Stock 14,315 $0.6 $8,589
Sale
Common Stock 14,315 $0.6 $8,589
Sale
Common Stock 8,467 $8.24 $69,793
Option
Stock Option (right to buy) 8,467 $8.24 $69,793
Option
Common Stock 8,467 $8.24 $69,793
Option
Stock Option (right to buy) 9,679 $0.6 $5,807
Sale
Common Stock 9,679 $0.6 $5,807
Option
Common Stock 9,679 $0.6 $5,807
Option
Common Stock 8,590 $8.58 $73,694
Option
Stock Option (right to buy) 8,590 $8.58 $73,694
Sale
Common Stock 8,590 $8.58 $73,694
Sale
Common Stock 22,726 $0.6 $13,636
Option
Stock Option (right to buy) 22,726 $0.6 $13,636
Option
Common Stock 22,726 $0.6 $13,636
Option
Stock Option (right to buy) 27,726 $0.6 $16,636
Sale
Common Stock 27,726 $0.6 $16,636
Option
Common Stock 27,726 $0.6 $16,636
Option
Stock Option (right to buy 14,041 $5.46 $76,594
Sale
Common Stock 14,041 $5.46 $76,594
Option
Common Stock 14,041 $5.46 $76,594
Option
Common Stock 18,233 $0.6 $10,940
Option
Stock Option (right to buy 18,233 $0.6 $10,940
Sale
Common Stock 18,233 $0.6 $10,940
Option
Stock Option (right to buy) 20,000 $0.6 $12,000
Sale
Common Stock 20,000 $0.6 $12,000
Option
Common Stock 20,000 $0.6 $12,000
Option
Stock Option (right to buy) 20,000 $0.6 $12,000
Option
Common Stock 20,000 $0.6 $12,000
Sale
Common Stock 20,000 $0.6 $12,000
Sale
Common Stock 2,585 $14.54 $37,596
Sale
Common Stock 19,504 $14.38 $280,370
Sale
Common Stock 311 $14.5 $4,510
Sale
Common Stock 7,600 $14.04 $106,727
Sale
Common Stock 2,312 $14.02 $32,410
Sale
Common Stock 217 $14 $3,038
Sale
Common Stock 200 $14 $2,800
Sale
Common Stock 556 $14 $7,784
Sale
Common Stock 75 $13.75 $1,031
Sale
Common Stock 16,726 $14.09 $235,669
Sale
Common Stock 422 $14 $5,908
Sale
Common Stock 1,980 $14 $27,720
Sale
Common Stock 2,503 $14 $35,042
Sale
Common Stock 3,873 $14 $54,234
Sale
Common Stock 3,075 $14 $43,050
Sale
Common Stock 1,154 $14 $16,156
Sale
Common Stock 1,323 $14.09 $18,641
Sale
Common Stock 3,064 $14 $42,896
Sale
Common Stock 5,982 $13.78 $82,420
Sale
Common Stock 9,018 $13.5 $121,743
Sale
Common Stock 7,500 $12.06 $90,473
Sale
Common Stock 999 $12.01 $11,997
Sale
Common Stock 1,101 $12.02 $13,232
Sale
Common Stock 2,000 $12 $24,000
Sale
Common Stock 3,400 $12.18 $41,422
Sale
Common Stock 15,000 $12.75 $191,250
Sale
Common Stock 22,500 $12.01 $270,113
Sale
Common Stock 15,000 $11.53 $172,950

ChemoCentryx key executives

ChemoCentryx, Inc. executives and other stock owners filed with the SEC: